Dr. Reddy's Stock Shows Slight Decline with Updated Market Data
Dr. Reddy's Laboratories' stock showed a slight decline from 1187.6 to 1180.0 between August 26 and 27, 2026, with market capitalization decreasing from approximately 99,735 crore to 98,659 crore. Both updates highlight consistent earnings per share of 38.6 and price-to-earnings ratios around 30.6 to 30.8. The coverage provides real-time data and expert analysis on fundamental and technical indicators to inform investors about the stock's performance.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 27/100.
Outlets measured: economictimes, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 26 Aug, 04:40 am. Other outlets followed.
- 1